Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maik Spreer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Alcoholism, Clinical and Experimental Research|March 20, 2021
Effects of moderate alcohol levels on default mode network connectivity in heavy drinkersXiaojing Fang, Yacila I Deza-Araujo, Johannes Petzold, et al.
Translational Psychiatry|April 5, 2023
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trialMaik Spreer, Xina Grählert, Ina-Maria Klut, et al.
Der Nervenarzt|August 22, 2024
[Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"]Ulrich S Zimmermann, Clemens Plickert, Christel Lüdecke, et al.
Depression and Anxiety|December 5, 2025
Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D StudyViktor B Nöhles, Felix Bermpohl, Nikola Schoofs, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Alcoholism, Clinical and Experimental Research|March 20, 2021
Effects of moderate alcohol levels on default mode network connectivity in heavy drinkersXiaojing Fang, Yacila I Deza-Araujo, Johannes Petzold, et al.
Translational Psychiatry|April 5, 2023
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trialMaik Spreer, Xina Grählert, Ina-Maria Klut, et al.
Der Nervenarzt|August 22, 2024
[Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"]Ulrich S Zimmermann, Clemens Plickert, Christel Lüdecke, et al.
Depression and Anxiety|December 5, 2025
Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D StudyViktor B Nöhles, Felix Bermpohl, Nikola Schoofs, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Pageof 2